+ Watch SRPT
on My Watchlist
A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.
It's not necessary for an investment to be in an ethical company, but it's a nice side-benefit. SRPT, has no significant side effects and the mainalternative for Duchenne sufferers is a heartbreaking slide into incapacity and death. This type of innovation is what modern medicine is for, and the FDA will approve it ASAP, and its developers (and investors) should and will, I believe, be richly rewarded. Dare I mention it will also make Duchenne sufferers more productive (therefore happier) members of society?
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions